Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management (Companion Faculty Lecture)
Research To Practice | Oncology Videos
00:00
Alternative Frontline Regimens and FOLFIRINOX Data
Strosberg reviews irinotecan substitution and promising retrospective FOLFIRINOX results leading to prospective trials for fit patients.
Play episode from 10:54
Transcript
